Overview
Charcot-Marie-Tooth disease type 4B3 (CMT4B3) is a very rare inherited nerve disorder that belongs to the larger family of Charcot-Marie-Tooth diseases, which are among the most common inherited neurological conditions. CMT4B3 specifically affects the peripheral nerves — the nerves that connect your brain and spinal cord to your muscles and sensory organs in your arms and legs. In this condition, the protective covering around nerves (called myelin) does not form properly, which slows down or disrupts nerve signals. People with CMT4B3 typically experience progressive muscle weakness and wasting, especially in the lower legs and feet, and later in the hands. This leads to difficulty walking, foot deformities such as high arches or hammertoes, and problems with balance. Sensation in the hands and feet may also be reduced, making it harder to feel temperature, pain, or touch. The disease tends to begin in childhood and slowly worsens over time. There is currently no cure for CMT4B3. Treatment focuses on managing symptoms and maintaining function. Physical therapy, occupational therapy, orthopedic devices like braces or special shoes, and sometimes surgery for foot deformities are the main approaches. Pain management may also be needed. Research into gene-based therapies and other disease-modifying treatments is ongoing but none are yet approved for this specific subtype.
Key symptoms:
Progressive muscle weakness in the legs and feetMuscle weakness in the hands and armsMuscle wasting (loss of muscle bulk) in the lower legsHigh foot arches (pes cavus)Hammertoes or other foot deformitiesDifficulty walking or frequent trippingBalance problemsReduced sensation or numbness in the feet and handsSlowed nerve conduction (demyelinating neuropathy)Fatigue during physical activityDecreased reflexesPossible scoliosis (curvature of the spine)Difficulty with fine motor tasks like buttoning clothes
Autosomal recessive
Passed on when both parents carry the same gene change; often skips generations
Childhood
Begins in childhood, roughly ages 1 to 12
Treatments
No FDA-approved treatments are currently listed for Charcot-Marie-Tooth disease type 4B3.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Charcot-Marie-Tooth disease type 4B3 at this time.
New trials open frequently. Follow this disease to get notified.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Charcot-Marie-Tooth disease type 4B3.
Community
No community posts yet. Be the first to share your experience with Charcot-Marie-Tooth disease type 4B3.
Start the conversation →Latest news about Charcot-Marie-Tooth disease type 4B3
No recent news articles for Charcot-Marie-Tooth disease type 4B3.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Questions for your doctor
Bring these to your next appointment
- Q1.How quickly is this condition likely to progress in my case or my child's case?,What medications or substances should we avoid because they can worsen nerve damage?,How often should we have follow-up nerve conduction studies or other monitoring?,What types of physical therapy exercises are most helpful for CMT4B3?,Are there any clinical trials or research studies we could participate in?,When should we consider orthopedic surgery for foot deformities?,Should other family members be tested for this gene mutation?
Common questions about Charcot-Marie-Tooth disease type 4B3
What is Charcot-Marie-Tooth disease type 4B3?
Charcot-Marie-Tooth disease type 4B3 (CMT4B3) is a very rare inherited nerve disorder that belongs to the larger family of Charcot-Marie-Tooth diseases, which are among the most common inherited neurological conditions. CMT4B3 specifically affects the peripheral nerves — the nerves that connect your brain and spinal cord to your muscles and sensory organs in your arms and legs. In this condition, the protective covering around nerves (called myelin) does not form properly, which slows down or disrupts nerve signals. People with CMT4B3 typically experience progressive muscle weakness and wasti
How is Charcot-Marie-Tooth disease type 4B3 inherited?
Charcot-Marie-Tooth disease type 4B3 follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Charcot-Marie-Tooth disease type 4B3 typically begin?
Typical onset of Charcot-Marie-Tooth disease type 4B3 is childhood. Age of onset can vary across affected individuals.
Which specialists treat Charcot-Marie-Tooth disease type 4B3?
16 specialists and care centers treating Charcot-Marie-Tooth disease type 4B3 are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.